RETRACTED ARTICLE: Development of attributes and attribute levels for a discrete choice experiment on patients’ and providers’ choice for antiretroviral therapy service in Northwest Ethiopia
Tóm tắt
Discrete choice experiments (DCEs) are used to assess the strength of preferences and value of interventions. However, researchers using this approach have been criticized for not conducting or publishing rigorous studies to select the required attributes and levels. Proper specification of attributes and their levels determines the validity of DCE. Hence, our study aimed to identify and define attributes and levels for the design of a DCE to elicit patients’ and providers’ preferences for ART service in Northwest Ethiopia. Four stages were followed to derive the final list of attributes and levels: (1) a literature review to derive conceptual attributes; (2) key informant interviews of 17 providers and in-depth interviews of 15 adult stable patients to identify context-specific attributes and attribute levels; (3) ranking survey among 31 HIV/AIDS program implementers and rating survey among 35 adult stable patients and 42 health workers providing antiretroviral therapy (ART) service to indicate participants’ preference of attributes; and (4) an expert opinion to reduce the list of attributes and levels. First, a literature review identified 23 candidate attributes. Second, individual-level analysis of the qualitative transcripts confirmed 15 of these 23 attributes. Third, the ranking and rating surveys put the importance of the 23 ART service attributes in order of preference. Fourth, through discussions with eight experts, 17 attributes were discarded based on multiple criteria. The six retained attributes were: the location of ART refills, the frequency of receiving ART refills, the person providing ART refills, the participants/others seen at the same ART refill visit, medication refill pick-up/delivery times, and the total cost of the visit during antiretroviral (ARV) medication refill. Finally, levels were assigned to these 6 attributes based on data from the literature, transcripts, and knowledge of the Ethiopian context. This detailed description illuminates the attribute development process and provides the reader with a basis for evaluating the rigor of this phase of DCE construction. This paper contributes empirical evidence to the limited methodological literature on attributes and levels of development for DCE, thereby providing further empirical guidance on ART service preference, specifically among patients of low- and middle-income countries.
Từ khóa
Tài liệu tham khảo
Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. J Value Health. 2011;14(4):403–13.
de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. J Health Econ. 2012;21(2):145–72.
Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care, vol. 11. Berlin: Springer; 2007.
Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. J Appl Health Econ Health Policy. 2003;2(1):55–64.
Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. J Pharmacoecon. 2019;37(2):201–26.
Hensher D, Rose J, Greene W. Applied choice analysis. 2nd ed. Cambridge: Cambridge University Press; 2015.
World Health Organization. How to conduct a discrete choice experiment for health workforce recruitment and retention in remote and rural areas: a user guide with case studies. Geneva; 2012. https://www.who.int/publications/i/item/9789241549684. Accessed 2 Dec 2022.
Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, Bresnahan BW, Kanninen B, Bridges JF. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. J Value Health. 2013;16(1):3–13.
Louviere JJ, Pihlens D, Carson R. Design of discrete choice experiments: a discussion of issues that matter in future applied research. J Choice Model. 2011;4(1):1–8.
Kjaer T. A review of the discrete choice experiment-with emphasis on its application in health care. Odense: Syddansk Universitet Denmark; 2005.
Dommaraju S, Hagey J, Odeny TA, Okaka S, Kadima J, Bukusi EA, Cohen CR, Kwena Z, Eshun-Wilson I, Geng E. Preferences of people living with HIV for differentiated care models in Kenya: a discrete choice experiment. J PLoS ONE. 2021;16(8):e0255650.
Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim H-Y, Zannolini A, Mwamba CP, Dowdy D, Kalunkumya E, Lumpa M, Beres LK, Roy M. Differentiated care preferences of stable patients on antiretroviral therapy in Zambia: a discrete choice experiment. J Acquir Immune Defic Syndr. 2019;81(5):540.
Opuni M, Bishai D, Gray GE, McIntyre JA, Martinson NA. Preferences for characteristics of antiretroviral therapy provision in Johannesburg, South Africa: results of a conjoint analysis. J AIDS Behav. 2010;14(4):807–15.
Strauss M, George G, Mantell JE, Mapingure M, Masvawure TB, Lamb MR, Zech JM, Musuka G, Chingombe I, Msukwa M. Optimizing differentiated HIV treatment models in urban Zimbabwe: assessing patient preferences using a discrete choice experiment. J AIDS Behav. 2021;25(2):397–413.
Zanolini A, Sikombe K, Sikazwe I, Eshun-Wilson I, Somwe P, Bolton Moore C, Topp SM, Czaicki N, Beres LK, Mwamba CP. Understanding preferences for HIV care and treatment in Zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up. J PLoS Med. 2018;15(8):e1002636.
Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, Ford N, Killingo B, Mabote L, Mansell T. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016.
Okere NE, Meta J, Maokola W, Martelli G, van Praag E, Naniche D, Gomez GB, Pozniak A, Rinke de Wit T, de Klerk J. Quality of care in a differentiated HIV service delivery intervention in Tanzania: a mixed-methods study. J PLoS ONE. 2022;17(3):e0265307.
Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. J Pharmacoecon. 2008;26(8):661–77.
Mangham LJ, Hanson K, McPake B. How to do (or not to do)… Designing a discrete choice experiment for application in a low-income country. J Health Policy Plan. 2009;24(2):151–8.
Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, Flynn TN. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. J Health Econ. 2012;21(6):730–41.
Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, DiSantostefano R, Peay H. Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and reviewers. Patient-Patient-Centered Outcomes Res. 2020;13:121–36.
Coast J, Horrocks S. Developing attributes and levels for discrete choice experiments using qualitative methods. J Health Serv Res. 2007;12(1):25–30.
Hiligsmann M, van Durme C, Geusens P, Dellaert BG, Dirksen CD, van der Weijden T, Reginster J-Y, Boonen A. Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis. J Patient Preference Adherence. 2013;7:133.
Ryan M, Scott DA, Donaldson C. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods. J Health Econ. 2004;23(2):237–58.
Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge: Cambridge University Press; 2000.
Gates R, McDaniel C, Braunsberger K. Modeling consumer health plan choice behavior to improve customer value and health plan market share. J Bus Res. 2000;48(3):247–57.
Helter TM, Boehler CEH. Developing attributes for discrete choice experiments in health: a systematic literature review and case study of alcohol misuse interventions. J Subst Use. 2016;21(6):662–8.
Belay YA, Yitayal M, Atnafu A, Taye FA. Patients’ preferences for antiretroviral therapy service provision: a systematic review. J Cost Eff Resour Alloc. 2021;19(1):1–25.
Belay YA, Yitayal M, Atnafu A, Taye FA. Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: a scoping review. J BMC Health Serv Res. 2022;22(1):1–23.
Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. J Field Methods. 2006;18(1):59–82.
Belay YA, Yitayal M, Atnafu A, Taye FA. Patient experiences and preferences for antiretroviral therapy service provision: implications for differentiated service delivery in Northwest Ethiopia. J AIDS Res Ther. 2022;19(1):1–16.
Belay YA, Yitayal M, Atnafu A, Taye FA. Experiences and preferences of providers towards differentiated antiretroviral therapy service delivery in Northwest Ethiopia. 2022.
Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. J Health Econ. 2018;27(1):157–71.
Lagarde M. Investigating attribute non-attendance and its consequences in choice experiments with latent class models. J Health Econ. 2013;22(5):554–67.
Kløjgaard ME, Bech M, Søgaard R. Designing a stated choice experiment: the value of a qualitative process. J Choice Model. 2012;5(2):1–18.
Obadha M, Barasa E, Kazungu J, Abiiro GA, Chuma J. Attribute development and level selection for a discrete choice experiment to elicit the preferences of health care providers for capitation payment mechanism in Kenya. J Health Econ Rev. 2019;9(1):1–19.
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021.